Vascular Dopamine and Dopamine Receptor Agonists
Regulation and modulation of the sympathetic nervous system have been and remain cornerstone strategies for the treatment of cardiovascular disease. Whereas stimulating, mimicking or antagonizing norepinephrine and epinphrine have been the most frequently utilized approach to cardiovascular renal therapeutics, the possibility that dopamine and dopamine receptors serve as useful target sites for drug action has received less attention.
KeywordsDopamine Receptor Adenylate Cyclase Dopamine Receptor Agonist Fusaric Acid Vascular Relaxation
Unable to display preview. Download preview PDF.
- Bell, C, and Lang, W., 1982, Is there a place for dopamine in autonomic neuromuscular transmission: in: Trends in Autonomic Pharmacology, Volume 2 (Stanley Kalsner, ed.), Urban & Schwarzenberg, Baltimore, pp. 263–282.Google Scholar
- Brodde, O.-E., and Meyer, F.-J., 1979, On the existence of vascular dopamine receptors on the isolated rabbit mesenteric artery, Naunyn Schmiedebergs Arch Pharmacol. 308(Suppl):R56.Google Scholar
- Crooks, R. J., and Martin, G. R., 1979, An isolated vascular tissue preparation showing a specific relaxant effect of dopamine, Br. J. Pharmacol. 67:474P.Google Scholar
- Forster, C, and Whalley, E. T., 1981, Dopamine receptors mediating relaxation of the human basilar artery in vitro, Br. J. Pharmacol. 74:944P–945P.Google Scholar
- Langer, S. Z., 1981, Presynaptic regulation of the release of catecholamines, Pharmacol. Rev. 32:337–362.Google Scholar
- McDonald,, R. H., and Goldberg, L. I., 1963, Analysis of the cardiovascular effects of dopamine in the dog, J. Pharmacol. Exp. Ther. 140:60–66.Google Scholar
- Schmidt, M., Imbs, J.-L., and Schwartz, J., 1979, Effets renaux de la bromocriptine, J. Pharmacol. (Paris) 10:525–532.Google Scholar
- Toda, N., 1978, Heterogeneity in the relaxation of vascular smooth muscle, in: Mechanisms of Vasodilation (P. M. Vanhoutte and J. Leusen, eds.), Karger, Basel, pp. 129–136.Google Scholar